• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆柠檬酸盐浓度:儿童青光眼的一种可能生物标志物。

Plasma citrate concentration: a possible biomarker for glaucoma in children.

作者信息

Michalczuk Marta, Tadeusz Porowski, Urban Beata, Anna Wasilewska, Bakunowicz-Łazarczyk Alina

机构信息

Department of Paediatric Ophthalmology and Strabismus, Medical University of Białystok, Białystok, Poland.

Department of Pediatrics and Nephrology, Medical University of Białystok, Białystok, Poland.

出版信息

BMJ Paediatr Open. 2017 Jul 3;1(1):e000023. doi: 10.1136/bmjpo-2017-000023. eCollection 2017.

DOI:10.1136/bmjpo-2017-000023
PMID:29637096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5843004/
Abstract

OBJECTIVES

The main aim of the present study was to examine a possible role of plasma and urine citrate levels as glaucoma indicators in school-aged children with glaucoma diagnosis.

PATIENTS

34 school-aged children with a glaucoma diagnosis (mean age 15.69±1.86 years) were qualified for the study group and 34 patients with no ophthalmological ailments were qualified for the control group (mean age 16.1±1.98 years). Plasma and urine citrate levels in the study and the control group (Kruskal-Wallis test) were compared.

RESULTS

Plasma citrate levels in the study (16.33±4.51 mg/L) and the control group (19.11±3.66 mg/L) were different; the statistical significance (p=0.0036). Plasma citrate concentrations were significantly lower in the study group in comparison with the control group. There were no statistically important differences between the study group (291.12±259.13 mg/24 hours; 275.82±217.57 mg/g) and the control group (434.88±357.66 mg/24 hours; 329.81±383.27 mg/g) including urine citrate level (p=0.052) and urine citrate to creatine ratio (p=0.4667).

CONCLUSION

Plasma citrate concentration might be considered as glaucoma biomarker in paediatric population.

摘要

目的

本研究的主要目的是探讨血浆和尿液中柠檬酸盐水平作为青光眼诊断指标在学龄期青光眼患儿中的可能作用。

患者

34名被诊断为青光眼的学龄儿童(平均年龄15.69±1.86岁)被纳入研究组,34名无眼科疾病的患者被纳入对照组(平均年龄16.1±1.98岁)。比较研究组和对照组的血浆和尿液柠檬酸盐水平(Kruskal-Wallis检验)。

结果

研究组(16.33±4.51mg/L)和对照组(19.11±3.66mg/L)的血浆柠檬酸盐水平不同;具有统计学意义(p=0.0036)。与对照组相比,研究组的血浆柠檬酸盐浓度显著降低。研究组(291.12±259.13mg/24小时;275.82±217.57mg/g)和对照组(434.88±357.66mg/24小时;329.81±383.27mg/g)之间在尿液柠檬酸盐水平(p=0.052)和尿液柠檬酸盐与肌酸比值(p=0.4667)方面没有统计学上的显著差异。

结论

血浆柠檬酸盐浓度可被视为儿童青光眼的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56dc/5843004/cef8f9fce408/bmjpo-2017-000023f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56dc/5843004/cef8f9fce408/bmjpo-2017-000023f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56dc/5843004/cef8f9fce408/bmjpo-2017-000023f01.jpg

相似文献

1
Plasma citrate concentration: a possible biomarker for glaucoma in children.血浆柠檬酸盐浓度:儿童青光眼的一种可能生物标志物。
BMJ Paediatr Open. 2017 Jul 3;1(1):e000023. doi: 10.1136/bmjpo-2017-000023. eCollection 2017.
2
Plasma citrate levels as a potential biomarker for glaucoma.血浆柠檬酸盐水平可作为青光眼的潜在生物标志物。
J Ocul Pharmacol Ther. 2011 Dec;27(6):577-80. doi: 10.1089/jop.2011.0062. Epub 2011 Sep 1.
3
Plasma GDF-15 concentration is not elevated in open-angle glaucoma.在开角型青光眼患者中,血浆 GDF-15 浓度没有升高。
PLoS One. 2021 May 28;16(5):e0252630. doi: 10.1371/journal.pone.0252630. eCollection 2021.
4
Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma.假性剥脱综合征、假性剥脱性青光眼和原发性开角型青光眼患者血浆中的同型半胱氨酸和一氧化氮水平。
Graefes Arch Clin Exp Ophthalmol. 2005 Jul;243(7):677-83. doi: 10.1007/s00417-004-1097-2. Epub 2005 Feb 2.
5
[The function-structure impairment pattern of optic nerves in primary open-angle glaucoma and normal-tension glaucoma].[原发性开角型青光眼和正常眼压性青光眼视神经的功能-结构损害模式]
Zhonghua Yan Ke Za Zhi. 2018 Nov 11;54(11):811-819. doi: 10.3760/cma.j.issn.0412-4081.2018.11.004.
6
Citrate usage in the leading causes of blindness: new possibilities for the old metabolite.柠檬酸盐在主要致盲原因中的应用:古老代谢物的新可能性
Metabolomics. 2018;14(6):82. doi: 10.1007/s11306-018-1377-1. Epub 2018 Jun 5.
7
Urine calcium/citrate ratio in children with hypercalciuric stones.高钙尿性结石患儿的尿钙/枸橼酸盐比值
Pediatr Res. 2009 Jul;66(1):85-90. doi: 10.1203/PDR.0b013e3181a2939e.
8
(1)H NMR-based metabolite profiling workflow to reduce inter-sample chemical shift variations in urine samples for improved biomarker discovery.基于¹H NMR的代谢物谱分析工作流程,以减少尿液样本中样本间的化学位移变化,从而改善生物标志物的发现。
Anal Bioanal Chem. 2016 Jul;408(17):4683-91. doi: 10.1007/s00216-016-9552-6. Epub 2016 May 13.
9
[Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].[尿枸橼酸盐水平对自发性二水草酸钙结晶尿的影响]
Prog Urol. 2005 Sep;15(4):650-5.
10
[The most important factor for active urinary stone formation in patients with urolithiasis].[尿石症患者活动性尿路结石形成的最重要因素]
Med Pregl. 2007;60 Suppl 2:117-20.

引用本文的文献

1
Pyruvate and related energetic metabolites modulate resilience against high genetic risk for glaucoma.丙酮酸及相关能量代谢产物可调节针对青光眼高遗传风险的恢复力。
Elife. 2025 Apr 24;14:RP105576. doi: 10.7554/eLife.105576.
2
Survey of eye patients' serum for biomarkers of primary open angle glaucoma in Gwagwalada, Nigeria: serum biomarkers for primary open angle glaucoma.尼日利亚瓜瓜瓦拉达地区原发性开角型青光眼患者血清生物标志物调查:原发性开角型青光眼的血清生物标志物
Int Ophthalmol. 2025 Apr 10;45(1):151. doi: 10.1007/s10792-025-03519-0.
3
Pyruvate and Related Energetic Metabolites Modulate Resilience Against High Genetic Risk for Glaucoma.

本文引用的文献

1
Mitochondria-Targeted Antioxidant SS-31 is a Potential Novel Ophthalmic Medication for Neuroprotection in Glaucoma.线粒体靶向抗氧化剂SS-31是一种用于青光眼神经保护的潜在新型眼科药物。
Med Hypothesis Discov Innov Ophthalmol. 2015 Fall;4(3):120-6.
2
Urinary citrate excretion in healthy children depends on age and gender.健康儿童的尿枸橼酸盐排泄量取决于年龄和性别。
Pediatr Nephrol. 2014 Sep;29(9):1575-82. doi: 10.1007/s00467-014-2806-7. Epub 2014 Apr 3.
3
Citrate--new functions for an old metabolite.柠檬酸盐——一种古老代谢物的新功能。
丙酮酸及相关能量代谢物可调节对青光眼高遗传风险的抵抗力。
bioRxiv. 2025 Mar 10:2025.01.18.633745. doi: 10.1101/2025.01.18.633745.
4
The profile of gut microbiota and central carbon-related metabolites in primary angle-closure glaucoma patients.原发性闭角型青光眼患者的肠道微生物群特征和中心碳相关代谢物。
Int Ophthalmol. 2022 Jun;42(6):1927-1938. doi: 10.1007/s10792-021-02190-5. Epub 2022 Feb 11.
5
Candidate Glaucoma Biomarkers: From Proteins to Metabolites, and the Pitfalls to Clinical Applications.青光眼候选生物标志物:从蛋白质到代谢物,以及临床应用中的陷阱
Biology (Basel). 2021 Aug 10;10(8):763. doi: 10.3390/biology10080763.
6
Citrate usage in the leading causes of blindness: new possibilities for the old metabolite.柠檬酸盐在主要致盲原因中的应用:古老代谢物的新可能性
Metabolomics. 2018;14(6):82. doi: 10.1007/s11306-018-1377-1. Epub 2018 Jun 5.
Biol Chem. 2014 Apr;395(4):387-99. doi: 10.1515/hsz-2013-0271.
4
Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible?青光眼病理影响的关键分子途径:是否可能进行预测性诊断?
EPMA J. 2010 Jun;1(2):237-44. doi: 10.1007/s13167-010-0031-4. Epub 2010 Jun 29.
5
Biomarkers in primary open angle glaucoma.原发性开角型青光眼的生物标志物。
Clin Chem Lab Med. 2012 Dec;50(12):2107-19. doi: 10.1515/cclm-2012-0048.
6
Unaltered myocilin expression in the blood of primary open angle glaucoma patients.原发性开角型青光眼患者血液中肌纤凝蛋白表达未改变。
Mol Vis. 2012;18:1004-9. Epub 2012 Apr 21.
7
Homocysteine and hydroxyproline levels in patients with primary open-angle glaucoma.原发性开角型青光眼患者的同型半胱氨酸和羟脯氨酸水平。
Curr Eye Res. 2012 Aug;37(8):712-8. doi: 10.3109/02713683.2012.669512. Epub 2012 Mar 29.
8
Plasma citrate levels as a potential biomarker for glaucoma.血浆柠檬酸盐水平可作为青光眼的潜在生物标志物。
J Ocul Pharmacol Ther. 2011 Dec;27(6):577-80. doi: 10.1089/jop.2011.0062. Epub 2011 Sep 1.
9
Proteomic analysis of aqueous humor from patients with primary open angle glaucoma.原发性开角型青光眼患者房水的蛋白质组学分析
Mol Vis. 2010 Dec 18;16:2839-46.
10
Glaucoma patients present increased levels of diadenosine tetraphosphate, Ap(4)A, in the aqueous humour.青光眼前房水中二磷酸四腺苷(Ap(4)A)水平升高。
Exp Eye Res. 2011 Mar;92(3):221-6. doi: 10.1016/j.exer.2010.12.004. Epub 2010 Dec 10.